Antwerp Cardiovascular Institute
Late luminal loss may be unreliable predictor of clinical effectiveness of drug-eluting stents
Published in Law and Health Weekly, May 13th, 2006
According to a study from Belgium, "Late luminal loss after percutaneous coronary intervention, although not normally distributed, has been shown to be monotonically correlated with the probability of binary angiographic restenosis after drug-eluting stent implantation. A recently proposed method has been shown to predict the restenosis rate after sirolimus-eluting stent and paclitaxel-eluting stent implantation using a power transformation of the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Cell Therapeutics, Inc.
Cell Therapeutics, Inc. granted U.S. patent for antitubulin agents with anti-cancer activity - Columbia University, New York
Cyclophilin A and TRIM5 alpha independently regulate HIV infectivity - DUA Pharmaceuticals, Inc.
DUSA Pharmaceuticals and New England Compounding Center announce favorable settlement - Federal University of Minas Gerais
Botulinum A toxin injected into gastric wall was safe treatment option for class III obesity - Grant Life Sciences, Inc.
DTL to develop, commercialize Grant's cervical cancer-diagnostic technology - Healthcare Coverage
Centers for Medicare and Medicaid Services (CMS) advises Niaspan is now Part D-eligible - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
